Psych MEQs / SAQs · Addiction psychiatry — behavioural addictions
Gambling disorder — criteria, risk, CBT, and naltrexone (MEQ)
FRANZCP-style MEQ on gambling disorder: DSM-5-TR criteria/severity, suicide-debt risk, CBT first-line, naltrexone off-label evidence, comorbidity and differentials.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Diagnosis and severity. He meets multiple DSM-5-TR gambling disorder criteria within 12 months (preoccupation/daily play, unsuccessful cut-downs, restlessness when stopping, chasing losses, lying/concealment, financial jeopardy/bailout trajectory). Threshold is ≥4 of 9; with many criteria endorsed this is at least moderate (6–7) and possibly severe (8–9) pending full criterion count. Note DSM-5 reclassification under addictive disorders and removal of the illegal-acts criterion relative to DSM-IV.[1]
(ii) Risk and dual diagnosis. Prioritise structured suicide risk assessment and safety planning after catastrophic disclosure and debt; assess intimate-partner conflict, child protection if dependents, and forensic exposure. Screen alcohol use disorder severity and withdrawal risk; mood, anxiety, ADHD, and personality pathology given NESARC-level comorbidity. Collateral from partner on true losses. Capacity around high-stakes financial decisions if relevant.[1][5]
(iii) Psychosocial first-line plan. Engage with MI despite psychology refusal — roll with resistance, link tablet request to comprehensive care. Offer CBT for gambling: cognitive restructuring of chasing and control illusions, urge surfing, stimulus control (app deletion, self-exclusion, bank blockers), behavioural alternatives, and financial counselling/debt plan with agreed third-party money management if safe. GA as adjunct. Couple session if appropriate. Measurement (e.g. G-SAS concept) and early review.[3][4]
(iv) Naltrexone counselling. Explain no formal GD monotherapy licence; evidence from placebo-controlled trials (Kim; Grant) supports urge reduction in selected patients as adjunct. Practical framing: oral naltrexone often discussed from about 50 mg daily after baseline labs, specialist titration if used, LFT monitoring — his ALT 62 warrants explanation, alcohol reduction plan, and caution rather than automatic high-dose starts. Contraindications include acute hepatitis/liver failure and current opioid use (precipitated withdrawal). Do not offer a tablet alone without psychosocial package.[2][6]
(v) Differential traps. (1) Unrecognised mania/hypomania driving betting — need sleep, grandiosity, and episode timeline. (2) Dopamine-agonist ICD if Parkinson/RLS drugs present (not in this stem but classic exam trap). Also: pure willpower framing; missing alcohol withdrawal risk.[1]
Common errors
- Claiming naltrexone is a licensed cure-all for GD.
- Ignoring suicide/debt while debating pokie brands.
- Omitting CBT evidence (Cowlishaw/Petry).
- Inventing Mental Health Act section numbers. [2][3]
Examiner notes
Full marks require accurate DSM-5-TR threshold/severity, explicit suicide-debt dual-diagnosis priorities, a named CBT package, and nuanced off-label naltrexone counselling with LFT/alcohol caveats.[1][2][4]
References
- [1]Potenza MN, et al. Gambling disorder Nat Rev Dis Primers, 2019.PMID 31346179
- [2]Grant JE, Kim SW, Hartman BK A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges J Clin Psychiatry, 2008.PMID 18384246
- [3]Cowlishaw S, et al. Psychological therapies for pathological and problem gambling Cochrane Database Syst Rev, 2012.PMID 23152266
- [4]Petry NM, et al. Cognitive-behavioral therapy for pathological gamblers J Consult Clin Psychol, 2006.PMID 16822112
- [5]Petry NM, Stinson FS, Grant BF Comorbidity of DSM-IV pathological gambling and other psychiatric disorders J Clin Psychiatry, 2005.PMID 15889941
- [6]Kim SW, Grant JE, Adson DE, Shin YC Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling Biol Psychiatry, 2001.PMID 11377409